A detailed history of Baird Financial Group, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 29,723 shares of CDNA stock, worth $622,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,723
Holding current value
$622,102
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.41 - $33.99 $428,308 - $1.01 Million
29,723 New
29,723 $927,000
Q3 2020

Nov 12, 2020

SELL
$30.88 - $37.94 $221,965 - $272,712
-7,188 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $136,212 - $254,670
7,188 New
7,188 $255,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.12B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.